In conclusion, from our results we proposed miR-190, miR-429 and miR-584 as diagnostic molecules for HER2+ BC, being miR-190 and miR-584 downregulated and miR-429 upregulated in HER2+ BC. This evidence concerns the gene ERBB2 and breast cancer.